Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Foghorn Therapeutics (FHTX) Receivables - Other (2021)

Foghorn Therapeutics has reported Receivables - Other over the past 1 years, most recently at $300.0 million for Q4 2021.

  • Quarterly results put Receivables - Other at $300.0 million for Q4 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $300.0 million (changed N/A YoY), and the annual figure for FY2021 was $300.0 million, changed.
  • Receivables - Other for Q4 2021 was $300.0 million at Foghorn Therapeutics.
  • Over the last five years, Receivables - Other for FHTX hit a ceiling of $300.0 million in Q4 2021 and a floor of $300.0 million in Q4 2021.